+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Agenus Inc - logo

Agenus is an immuno-oncology company that focuses on the discovery and development of treatments that engage the body's immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates. It is also developing Prophage, a heat shock protein-based autologous vaccine. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Cervical Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Cervical Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
CTLA-4 inhibitors- Competitive landscape, 2023 - Product Thumbnail Image

CTLA-4 inhibitors- Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
Checkpoint Inhibitors - Competitive landscape, 2023 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive landscape, 2023

  • Report
  • April 2023
  • 350 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2020-2025 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2020-2025

  • Report
  • September 2025
  • 1000 Pages
  • Global
From
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025 - Product Thumbnail Image

Monoclonal Antibody Collaboration and Licensing Deals 2019-2025

  • Report
  • May 2025
  • 350 Pages
  • Global
From
Oncolytic Virus - Competitive Landscape, 2022 - Product Thumbnail Image

Oncolytic Virus - Competitive Landscape, 2022

  • Report
  • October 2022
  • 300 Pages
  • Global
From
Cervical Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Cervical Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 225 Pages
  • Global
From
Pancreatic Cancer - Competitive Landscape, 2024 - Product Thumbnail Image

Pancreatic Cancer - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 550 Pages
  • Global
From
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025 - Product Thumbnail Image

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025

  • Report
  • September 2025
  • 550 Pages
  • Global
From
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025

  • Report
  • September 2025
  • 750 Pages
  • Global
From
Wearable Injectors Market Industry Trends and Global Forecasts to 2035, by Type of Device, Usability, Therapeutic Area and Key Geographical Regions - Product Thumbnail Image

Wearable Injectors Market Industry Trends and Global Forecasts to 2035, by Type of Device, Usability, Therapeutic Area and Key Geographical Regions

  • Report
  • January 2025
  • 690 Pages
  • Global
From
Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape - Product Thumbnail Image

Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape

  • Report
  • March 2023
  • 182 Pages
  • Global
From
Liposome Development and Liposome Manufacturing Services Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product Formulation, Scale of Operation, Type of End User, and Key Geographical Regions - Product Thumbnail Image

Liposome Development and Liposome Manufacturing Services Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product Formulation, Scale of Operation, Type of End User, and Key Geographical Regions

  • Report
  • March 2025
  • 230 Pages
  • Global
From
LAG-3 Targeting Therapy Market, Drug Dosage, Patent, Sales & Clinical Trials Insight 2030 Report - Product Thumbnail Image

LAG-3 Targeting Therapy Market, Drug Dosage, Patent, Sales & Clinical Trials Insight 2030 Report

  • Report
  • April 2025
  • 190 Pages
  • Global
From
LAG-3-Next Generation Immunotherapy - Competitive Landscape and Market Forecast-2035 - Product Thumbnail Image

LAG-3-Next Generation Immunotherapy - Competitive Landscape and Market Forecast-2035

  • Report
  • April 2020
  • 80 Pages
  • Global
From
Head And Neck Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 3419 Pages
  • Global
From
Glioma - Competitive Landscape, 2023 - Product Thumbnail Image

Glioma - Competitive Landscape, 2023

  • Report
  • April 2023
  • 450 Pages
  • Global
From
TIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insight 2028 - Product Thumbnail Image

TIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insight 2028

  • Report
  • July 2022
  • 111 Pages
  • Global
From
Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025 - Product Thumbnail Image

Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
Loading Indicator